Skip to main content
SpringerLink
Log in

CABG best bet for most patients with CAD in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. including those associated with procedures, post-procedural hospitalisation, physician time and outpatient care

Reference

  • Cohen DJ, et al. Cost-Effectiveness of Percutaneous Coronary Intervention with Drug-Eluting Stents vs. Bypass Surgery for Patients with 3-Vessel or Left Main Coronary Artery Disease: Final Results from the SYNTAX Trial. Circulation : Aug 2014. Available from: URL: http://doi.org/10.1161/CIRCULATIONAHA.114.009985

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CABG best bet for most patients with CAD in the US. PharmacoEcon Outcomes News 709, 3 (2014). https://doi.org/10.1007/s40274-014-1445-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1445-3

Search

Navigation